Evidence map›Paper›PMID 41574434›Full record

ArticleNucleic acids research2026

ADAM-tRNA-seq: an optimized approach for demultiplexing and enhanced hierarchal mapping in direct tRNA sequencing.

Rodrigo Alarcon, Daniel Köster, Stine Behrmann, Zoya Ignatova

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rodrigo AlarconInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg 20146, Germany.
Daniel KösterInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg 20146, Germany.
Stine BehrmannInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg 20146, Germany.
Zoya IgnatovaInstitute of Biochemistry and Molecular Biology, University of Hamburg, Hamburg 20146, Germany.ORCID 0000-0002-9478-8825

Funding

Ribosomal perturbation as a mechanism to prevent misfolding of CFTRR01HL136414 · NHLBI · EMORY UNIVERSITY · PI HARTMAN, JOHN L, SORSCHER, ERIC J · 2018 to 2025
$4.5M
Action for A-T UK; Hamburg Innovation C4T projects C4T635Deutsche Forschungsgemeinschaft 520471345Deutsche Forschungsgemeinschaft CRC 1678Deutsche Forschungsgemeinschaft IG73/21-1Deutsche Forschungsgemeinschaft RA3259/2-1NHLBI NIH HHS R01 HL136414NIH HHS 1R01HL136414-05Volkswagenstiftung 98188Volkswagenstiftung AZ 98188
6 · The paper itself

Abstract

Transfer RNAs (tRNAs) play an essential role in protein synthesis and cellular homeostasis, and their dysregulation is associated with various human pathologies. Recent advances in direct RNA sequencing by the Nanopore platform have enabled simultaneous profiling of tRNA abundance, modifications, and aminoacylation status. However, the high sequence similarity among tRNAs and the lack of robust demultiplexing strategies reduce the accuracy and limit the scalability of current approaches. Here, we developed ADAM-tRNA-seq, a framework that addresses two key limitations of the Nanopore-based direct tRNA sequencing. First, we develop an RNA-based barcode demultiplexing method, that employs a barcode embedded in the sequencing adapter, recognized by the Dorado basecaller. Second, we designed a hierarchy-based mapping strategy that mitigates read loss due to multimapping by classifying reads at the isodecoder, isoacceptor, or isotype levels, thereby enhancing quantification accuracy. We validated ADAM-tRNA-seq using both synthetic tRNAs and a complex human tRNA pool, and systematically optimized it to achieve up to 99% classification precision. Together, these developments enable more accurate, scalable, and comprehensive characterization of tRNA pools across diverse sample types.

Indexed as

High-Throughput Nucleotide SequencingRNA, TransferSequence Analysis, RNAHumansRNA, Transfer

Identifiers

PMID41574434
PMCPMC12828228

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.